Shares of Co-Diagnostics, Inc. (CODX) are up more than 5% in the morning trade on Monday at $6.29.
The molecular diagnostics company today said it has shipped testing reagents for monkeypox virus to one of its international distributors.
As of July 7, 2022, over 6,000 cases of monkeypox have been reported to WHO from 59 countries, the company said.
CODX has traded in the range of $3.66-$11.82 in the past 52 weeks.
Source: Read Full Article
Lates News:
-
Axos Financial Adds 11% In Morning Trade
-
How Cryptos Fared In November?
-
Bitcoin, ETH, XRP, ADA Get Stuck In Tight Ranges As Investors Attune To The Jackson Hole Symposium
-
U.S. Presidential Hopeful Robert F. Kennedy Jr. Brings Bitcoin to the Campaign Trail
-
Barnes & Noble Education Rallies On Increased Sales In Q1
